Psychological, physiological, and drug interventions for type 2 diabetes

Lancet

Volumn 363, Issue 9421, 2004, Pages 1569-1570

  Jenkins, David J A ^a  

^a ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT;

BLOOD GLUCOSE MONITORING; CHRONIC DISEASE; CLINICAL TRIAL; DIET; DISTRESS SYNDROME; EXERCISE; GLUCOSE BLOOD LEVEL; HEALTH CARE; HEALTH CARE QUALITY; HEALTH PROMOTION; HOSPITAL; HUMAN; INSULIN INFUSION; MEDICAL INFORMATION; META ANALYSIS; MICROANGIOPATHY; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PHYSIOLOGY; PRIORITY JOURNAL; PROPHYLAXIS; PSYCHOLOGIC ASSESSMENT; PSYCHOTHERAPY; STRESS; TYPES OF STUDY; WEIGHT REDUCTION;

EID: 2442520611     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(04)16236-3     Document Type: Note

References (5)

1. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 346:2002;393-403
2. UK Prospective Diabetes Study Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998; 352: 837-53.
3. Miller WR. Motivational interviewing: research, practice, and puzzles. Addict Behav. 21:1996;835-842
4. Miller WR, Rollnick S. Motivational interviewing: preparing people to change addictive behavior. 1991;Guilford Press, New York
5. Rollnick S, Miller WR. What is motivational interviewing? Behav Cog Psychol. 23:1995;325-334